We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
NovaLisa® SARS-CoV-2 IgG (1x96)
The NovaLisa® SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of IgG class antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The assay is CE-IVD marked The ELISA antibody detection assays are an ideal supplement for the direct pathogen detection and are a valuable tool for epidemiological studies.
The ELISA kits demonstrate high sensitivity and specificity: antibodies were detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group). The specificity is >98%.*
* Initial testing on more than 300 samples. Please refer to the product inserts for more details.
If you are from Germany, please visit this product page.
If you are from the US, please visit this product page.
Related Products
The NovaLisa® SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The assay is CE-IVD marked.
Assay Features
• Separate Detection of IgG antibodies
• SARS-CoV-2 Nucleocapsid recombinant antigen
• Ideal complement to RT-PCR
• Ready-to-use controls
• Results in 2 hours
• Assay procedure is easy to automate
• Works on any open ELISA system (protocols available)
• CE-IVD
| SKU | COVG0940 |
|---|---|
| Test principle | Enzyme-linked Immunosorbent Assay |
| Format | Microtiter plate with 96 wells |
| Incubation Time | 2 hours |
| Storage | 2–8°C |